Since in AML the enrichment of LSCs is well established and the CD34+CD38- fraction is suggested to contain the most important LSCs[17], the surface markers CD34 and CD38 have also often been used to enrich for LSCs in B-ALL[156]. The gene discussed is CD34; the disease is precursor B-cell acute lymphoblastic leukemia.